For The Better

These three stocks are solid value picks in different areas of healthcare.

The COVID-19 pandemic hurt these businesses, but they emerged stronger than ever.

It could be a disruptor to traditional businesses.

If you aren’t eligible for Social Security yet, you need to know this news.

CEO Andrea Olshan’s turnaround strategy hasn’t inspired investors, so Seritage is now considering bolder moves to unlock value for shareholders.

Three decades of outperformance doesn’t mean there aren’t still bargains to be found in the Nasdaq 100.

Friends in high places and a compelling emerging market add stability to Lucid’s short-term woes.

Workiva has become a critical data unification tool for large companies, and its opportunity is only growing.

These stocks are down big over the past year, but investors shouldn’t count them out over the long haul.

You don’t have to give up your tech investments to generate passive income.

Reserves were needed to remedy a one in a million scenario.

The answers could lead to the right decisions.

It could be time to get greedy with these three stocks.

Heightened market volatility amid increasing geopolitical tensions can prove to be an attractive entry opportunity for savvy investors.

These biotechs have promising near-term and long-term prospects.

You don’t have to worry that benefits won’t be there for you.